This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
/ / /
/ / /

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.

 

This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.

 

This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

Bleeding is common

People with haemophilia still face problems

Haemophilia limits the physical freedom

Haemophilia can impact a person’s ability

Staying adherent to haemophilia

Living with haemophilia

Heinz vetterli

“When I was young there was no treatment at all. Looking back at six decades of haemophilia treatment, the care of the haemophilia patient has changed enormously”

Heinz vetterli

“When I was young there was no treatment at all. Looking back at six decades of haemophilia treatment, the care of the haemophilia patient has changed enormously”

Linda


Linda shares her story of being diagnosed with acquired haemophilia - a rare bleeding disorder - at the age of 45.
Harry and Olivia


Diagnosed very early in his life, Harry and his mum Olivia share their experience from a patient perspective as well as from a carer's perspective.
Heinz


Heinz tells his story of living his life with haemophilia and sharing insights of how the haemophilia care changed in the last 60 years.

1.

Gualtierotti R et al. Thromb Haemost. 2021;19(9):2112–2121;

2.

Hermans C et al. Blood Rev. 2022;52:100890;

3.

Srivastava A et al. Haemophilia. 2020;26(Suppl 6):1–158;

4.

Skinner MW et al. Haemophilia. 2020;26:17–24;

5.

Baumann K et al. Eur J Haematol. 2017;98:25–34;

6.

Burke T et al. Orphanet J Rare Dis. 2021;16:52;

7.

Peyvandi F et al. Haemophilia. 2019;25:755–763;

8.

Tischer B et al. Patient Prefer Adherence. 2018;12:431–441;

9.

Mahlangu J et al. Haemophilia. 2019;25:382–391;

10.

Cutter S et al. Eur J Haematol. 2017;98:18–24;

 

The information contained in this site is intended for healthcare professionals only outside of the United States of America. This site is not intended to provide medical advice and/or treatment guidance. Only a physician can determine whether a specific product is correct for a particular patient. This site is not country-specific and therefore may contain information which is not applicable to your country. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional. Any images shown are models and not real patients.



HQ24CH00001, March 2024